Abstract
The dynamics of hepatitis C virus (HCV) RNA during translation and replication were added to an age-based multiscale mathematical model of HCV infection and treatment. The model allows the study of the production of HCV inside infected cells, which are later released as virus in the plasma, available to infect other cells. This is the first model to our knowledge to consider both positive and negative strands of HCV RNA with an age-based multiscale approach. Simulation of the effectiveness of direct acting antiviral (DAA) drugs in blocking HCV RNA intracellular production and release of new virions, and enhancing their depletion were performed. Changes on the set of parameters allowed the validation of the model comparing it to distinct experiments: in vitro and in vivo under therapy.
Preview
Unable to display preview. Download preview PDF.
References
WHO . Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection 2016. Date accessed: July, 2016.
Gastaminza P., Cheng G., Wieland S., Zhong J., Liao W., Chisari F. V.. Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion Journal of Virology. 2008;82:2120–2129.
Appel N., Schaller T., Penin F., Bartenschlager R.. From Structure to Function: New Insights into Hepatitis C Virus RNA Replication Journal of Biological Chemistry. 2006;281:9833–9836.
Afzal M. S., Alsaleh K., Farhat R., et al. Regulation of Core Expression During the Hepatitis C Virus Life Cycle Journal of General Virology. 2015;96:311–21.
Craggs J K, Ball J K, Thomson B J, Irving W L, Grabowska AM. Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA J Virol Methods. 2001;94:111–20.
Goutagny N., Inchauspe G.. Emerging Therapies for Hepatitis C Infectionch. 12. Human Virus GuidesInternational Medical Press 2009.
Liang T. Jake, Ghany Marc G.. Current and Future Therapies for Hepatitis C Virus Infection The New England Journal of Medicine. 2013;368:1907–1917.
Myers R. P., Shah H., Burak K. W., Cooper C., Feld J. J.. An update on the management of the chronic Hepatitis C: 2015 consensus guidelines from the Canadian Association for the Study of the Liver Can J Gastroenterol Hepatol. 2015;(In press).
Rong L., Guedj J., Dahari H., et al. Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model PLOS Computational Biology. 2013;9:e1002959.
Guedj J., Neumann A.U.. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics Journal of Theoretical Biology. 2010;267:330–340.
Dixit N. M.. Advances in the mathematical modelling of Hepatitis C virus dynamics Journal of the Indian Institute of Science. 2008;88:37–43.
Dahari H., Layden–Almer J. E., Kallwitz E., et al. A Mathematical Model of Hepatitis C Virus Dynamics in Patients With High Baseline Viral Loads or Advanced Liver Disease Gastroenterology. 2009;136:1402–1409.
Ribeiro R. M., Li H., Wang S., et al. Quantifying the Diversification of Hepatitis C Virus (HCV) during Primary Infection: Estimates of the In Vivo Mutation Rate PLOS Pathogens. 2012;8:e1002881.
Canini L., Perelson A. S.. Viral kinetic modeling: state of the art J Pharmacokinet Pharmacodyn. 2014;41:431–443.
Chaterjee A., Guedj J., Perelson A. S.. Mathematical Modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents? Antiviral Therapy. 2012;17:1171–1182.
Dahari H., Sainz B., Perelson A. S., Uprichard S. L.. Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon Journal of Virology. 2009;83:6383–6390.
Banerjee S., Keval R., Gakkhar S.. Modeling the dynamics of Hepatitis C virus with combined antiviral drug therapy: Interferon and Ribavirin Mathematical Biosciences. 2013;245:235 – 248.
Guedj J., Perelson A. S.. Second-phase Hepatitis C Virus RNA Decline During Telaprevir-Based Therapy Increases With Drug Effectiveness: Implications for Treatment Duration Viral Hepatitis. 2011;53:1801–8.
Guedj J., Dahari H., Rong L., et al. Modeling Shows that the NS5A inhibitor dacatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life PNAS. 2013;110:3991-3996.
Thieme H., Castillo-Chavez C.. How may infection-age-dependent infectivity affect the dynamics of HIV/AIDS? SIAM J. Appl. Math.. 1993;53:1337–79.
Martcheva M., Castillo-Chavez C.. Diseases with chronic stage in population with varying size? Math. Biosci.. 2003;182:1–25.
Thieme H., Castillo-Chavez C.. A two-strain tuberculosis model with age infection SIAM J. Appl. Math.. 2002;62:1634–56.
Nelson P. W., Gilchrist M. A., Coombs D., Hyman J. M., Perelson A. S.. An age-structured model of HIV Infection that Allows for Variations in the Death Rate of Productively Infected Cells Mathematical Biosciences. 2004;1.
Li Jia, Brauer Fred. Continuous-Time Age-Structured Models in Population Dynamics and Epidemiology in Mathematical Epidemiology (Brauer Fred, Driessche Pauline, Wu Jianhong. , eds.);1945 of Lecture Notes in Mathematics:205–227Springer Berlin Heidelberg 2008.
Moradpour D., Penin F., Rice C. M.. Replication of hepatitis C virus Nature Reviews Microbiology. 2007;5:453–463.
Shi S. T., Lai M. M. C.. HCV 5’ and 3’UTR: When Translation Meets Replicationch. 2. Norfolk (UK): Horizon Bioscience: in: Hepatitis C Viruses: Genomes and Molecular Biology. Tan SL, editor 2006. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1624/.
Keum S.J., Park S.M., Park J.H., Jung J.H., Shin E.J., Jang S.K.. The specific infectivity of hepatitis C virus changes through its life cycle Virology. 2012;433:462–470.
Neumann A. U., Lam N.P., Dahari H., Gretch D.R., Wiley T. E., al. . Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science. 1998;282:103–107.
Lee C.. Daclatasvir: potential role in hepatitis C Drug Des Devel Ther.. 2013;7:1223–1233.
Scheel T. K. H., Rice C. M.. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies Nat. Med.. 2013;19:837–849.
Webster B., Ott M., Greene W. C.. Evasion of Superinfection Exclusion and Elimination of Primary Viral RNA by an Adapted Strain of Hepatitis C Virus Journal of Virology. 2013;87:13354–13369.
Sanjuán R., Nebot M. R., Chirico N., Mansky L. M., Belshaw R.. Viral Mutation Rates Journal of Virology. 2010;84:9733–9748.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Quintela, B.M. et al. (2017). An Age-based Multiscale Mathematical Model of the Hepatitis C Virus Life-cycle During Infection and Therapy: Including Translation and Replication. In: Torres, I., Bustamante, J., Sierra, D. (eds) VII Latin American Congress on Biomedical Engineering CLAIB 2016, Bucaramanga, Santander, Colombia, October 26th -28th, 2016. IFMBE Proceedings, vol 60. Springer, Singapore. https://doi.org/10.1007/978-981-10-4086-3_128
Download citation
DOI: https://doi.org/10.1007/978-981-10-4086-3_128
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4085-6
Online ISBN: 978-981-10-4086-3
eBook Packages: EngineeringEngineering (R0)